Clinical trial
A Randomized Controlled Study on the Effect of S-Adenosyl Methionine Treatment on Anti-tumor Recurrence After Radical Treatment of Primary Hepatic Carcinoma
NCT03178929 is registered in ClinicalTrials.gov with Beijing Insight Science & Technology Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study on the Effect of S-Adenosyl Methionine Treatment on Anti-tumor Recurrence After Radical Treatment of Primary Hepatic Carcinoma
- Lead sponsor
- Beijing Insight Science & Technology Co. Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2017
- Completion date
- August 31, 2020
- Enrollment
- 207 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
primary liver cancer